Bone Grafting for Scaphoid Nonunions: Is Free Vascularized Bone Grafting Superior for Scaphoid Nonunion?


Journal

Hand (New York, N.Y.)
ISSN: 1558-9455
Titre abrégé: Hand (N Y)
Pays: United States
ID NLM: 101264149

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 29 10 2017
medline: 25 2 2020
entrez: 29 10 2017
Statut: ppublish

Résumé

Nonvascularized bone grafting (NVBG) and vascularized bone grafts (VBGs) have been used to treat scaphoid nonunions. A comparison of a single institution' s experience using structural iliac crest bone graft (ICBG), 1,2-intercompartmental supraretinacular artery (1,2-ICSRA), and medial femoral condyle (MFC) grafts to treat scaphoid nonunions was undertaken. Thirty-one patients underwent ICBG, 33 patients underwent 1,2-ICSRA, and 45 patients underwent MFC grafting. Mean time to follow-up was 16 months (range, 2-153). Twenty-three percent used tobacco products. Mean age was 24 years (range, 11-66), with 86% male patients. Outcomes included union rate, time to healing, range of motion, complications, and reoperations. Union rates and mean time to union were 71% and 19 weeks for the ICBG group, 79% and 26 weeks for the 1,2-ICSRA group, and 89% and 16 weeks for the MFC group, respectively. Failure of union was associated with tobacco use but not with age, gender, time from injury to surgery, or type of fixation. There was no significant difference between the groups regarding range of motion or strength. These findings demonstrate the need for careful patient selection. In patients with the most complicated scaphoid nonunions (avascular necrosis, carpal collapse, and previous surgeries), the MFC group had the highest union rate and fastest time to union. Patients with risk factors for failure should be counseled on the outcomes and possible need for salvage fusion surgery.

Sections du résumé

BACKGROUND
Nonvascularized bone grafting (NVBG) and vascularized bone grafts (VBGs) have been used to treat scaphoid nonunions. A comparison of a single institution' s experience using structural iliac crest bone graft (ICBG), 1,2-intercompartmental supraretinacular artery (1,2-ICSRA), and medial femoral condyle (MFC) grafts to treat scaphoid nonunions was undertaken.
METHODS
Thirty-one patients underwent ICBG, 33 patients underwent 1,2-ICSRA, and 45 patients underwent MFC grafting. Mean time to follow-up was 16 months (range, 2-153). Twenty-three percent used tobacco products. Mean age was 24 years (range, 11-66), with 86% male patients. Outcomes included union rate, time to healing, range of motion, complications, and reoperations.
RESULTS
Union rates and mean time to union were 71% and 19 weeks for the ICBG group, 79% and 26 weeks for the 1,2-ICSRA group, and 89% and 16 weeks for the MFC group, respectively. Failure of union was associated with tobacco use but not with age, gender, time from injury to surgery, or type of fixation. There was no significant difference between the groups regarding range of motion or strength.
CONCLUSIONS
These findings demonstrate the need for careful patient selection. In patients with the most complicated scaphoid nonunions (avascular necrosis, carpal collapse, and previous surgeries), the MFC group had the highest union rate and fastest time to union. Patients with risk factors for failure should be counseled on the outcomes and possible need for salvage fusion surgery.

Identifiants

pubmed: 29078719
doi: 10.1177/1558944717736397
pmc: PMC6436125
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

217-222

Références

J Hand Surg Am. 1989 Sep;14(5):800-6
pubmed: 2794394
Skeletal Radiol. 1995 May;24(4):271-3
pubmed: 7644940
J Hand Surg Am. 1991 May;16(3):474-8
pubmed: 1861030
J Bone Joint Surg Am. 1985 Mar;67(3):428-32
pubmed: 3972868
J Hand Surg Am. 2006 Mar;31(3):387-96
pubmed: 16516732
Arch Orthop Trauma Surg. 1999;119(5-6):285-7
pubmed: 10447624
J Hand Surg Br. 1993 Apr;18(2):219-24
pubmed: 8501380
J Hand Surg Eur Vol. 2015 Oct;40(8):848-54
pubmed: 25487319
J Hand Surg Am. 2002 Jul;27(4):685-91
pubmed: 12132096
J Hand Surg Br. 2001 Aug;26(4):330-4
pubmed: 11469835
J Am Acad Orthop Surg. 2003 Nov-Dec;11(6):380-91
pubmed: 14686823
J Hand Surg Am. 2000 May;25(3):507-19
pubmed: 10811756
J Hand Surg Am. 1987 Jul;12(4):514-9
pubmed: 3611645
J Hand Surg Br. 2000 Jun;25(3):266-70
pubmed: 10961552
Tech Hand Up Extrem Surg. 2007 Dec;11(4):246-58
pubmed: 18090830
J Bone Joint Surg Br. 1996 Jul;78(4):530-4
pubmed: 8682814
J Hand Surg Am. 1989 Jul;14(4):679-87
pubmed: 2787817
J Bone Joint Surg Am. 2008 Dec;90(12):2616-25
pubmed: 19047706
J Hand Surg Am. 2013 Apr;38(4):701-5
pubmed: 23415167
J Bone Joint Surg Am. 1994 Jan;76(1):88-94
pubmed: 8288669
Clin Orthop Relat Res. 1996 Jun;(327):98-109
pubmed: 8641090
J Hand Surg Am. 2002 May;27(3):391-401
pubmed: 12015712
Chir Main. 2010 Dec;29 Suppl 1:S93-103
pubmed: 21087887
Orthop Rev. 1994 Nov;23(11):861-71
pubmed: 7854839
J Bone Joint Surg Am. 1984 Apr;66(4):504-9
pubmed: 6707028
J Am Acad Orthop Surg. 2002 May-Jun;10(3):210-6
pubmed: 12041942
Scand J Plast Reconstr Surg Hand Surg. 1999 Dec;33(4):423-6
pubmed: 10614752
Plast Reconstr Surg. 2010 Apr;125(4):1176-84
pubmed: 20335867

Auteurs

William R Aibinder (WR)

1 Mayo Clinic, Rochester, MN, USA.

Eric R Wagner (ER)

1 Mayo Clinic, Rochester, MN, USA.

Allen T Bishop (AT)

1 Mayo Clinic, Rochester, MN, USA.

Alexander Y Shin (AY)

1 Mayo Clinic, Rochester, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH